About Ebenbuild
Ebenbuild is a Healthcare company based in Munchen (Germany) founded in 2018 by Wolfgang Wall, Kei Muller, Jonas Biehler, and Karl-Robert Wichmann. Digital twin-based precision therapy for ARDS ventilation is provided. It operates in the Healthcare and Technology sectors. Ebenbuild has raised $2.78 million across 3 funding rounds from investors including European Commission, Bayern Kapital and High-Tech Gründerfonds. Its chief executive, as recorded, is Kei Muller. Ebenbuild offers products and services including Clinical Decision Support and In Silico Trials. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is Ebenbuild GmbH.
Company details
Ebenbuild was founded in 2018 in Munich, Germany, and operates in the health technology sector. Precision therapy solutions based on digital twins are developed to optimize mechanical ventilation settings for patients with Acute Respiratory Distress Syndrome. Predictive computational models are utilized to offer individualized protective ventilation protocols, aiming to reduce ventilator-induced lung damage and support recovery outcomes.
- Headquarters Munchen, Germany
- Founders Wolfgang Wall, Kei Muller, Jonas Biehler, Karl-Robert Wichmann
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website ebenbuild.com
- Social LinkedIn X
- Legal Name Ebenbuild Gmbh
- Total Equity Funding$2.78M (USD)
in 3 rounds
- Latest Funding Round$2.71M (USD), Grant
Jul 2025
- InvestorsEuropean Commission
& 3 more
Products & Services of Ebenbuild
Ebenbuild offers a comprehensive portfolio of products and services, including Clinical Decision Support and In Silico Trials.
Platform for informing efficient treatment decisions in hospitals.
Tool for optimizing drug delivery and tracking respiratory diseases.
Funding Insights of Ebenbuild
Ebenbuild has successfully raised a total of $2.78M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.71 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.78M
- Total Rounds 3
- Last Round Grant — $2.71M
- Investors Count 4
All 3 funding rounds of Ebenbuild with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2025 | $2.71M | Grant | – | – | |
| Mar 2022 | $2.78M | Seed | – | Bayern Kapital, HTGF | – |
| Dec 2020 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Ebenbuild
Ebenbuild has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Commission, Bayern Kapital and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
High-tech industries are targeted for investments by Bayern Kapital. | bayernkapital.de | Landshut, Germany | ||
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
TechFounders is engaged in fostering partnerships between corporates and startups. | techfounders.com | |||
Institution of the European Union responsible for upholding the EU treaties | 1958 | ec.europa.eu | Brussels, Belgium |
Investor details for Ebenbuild
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ebenbuild
8 people are tracked at Ebenbuild (6 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Wolfgang Wall | Co-Founder | Leadership |
Kei Muller | Co-Founder & CEO | Leadership |
Jonas Biehler | Co-Founder | Leadership |
Karl-Robert Wichmann | Co-Founder | Leadership |
Kei Wieland Müller | Chief Executive Officer | Leadership |
Maximilian Grill | Head Of In Silico Trials | Leadership |
Jakob Richter | Senior Software & Project Engineer | Team |
Nina Pischke | Product Lead | Team |
Complete people profiles for Ebenbuild
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ebenbuild
3 dated milestones of Ebenbuild across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Ebenbuild is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $2.7M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ebenbuild
Complete news archive for Ebenbuild
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ebenbuild
Ebenbuild was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Ebenbuild is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Kei Muller is the CEO of Ebenbuild, as recorded in our data. They have also founded this company.
Ebenbuild is a funded company, having raised a total of $2.78M across 3 funding rounds to date.
Ebenbuild was founded in 2018 in Munich, Germany, and operates in the health technology sector. Precision therapy solutions based on digital twins are developed to optimize mechanical ventilation settings for patients with Acute Respiratory Distress Syndrome. Predictive computational models are utilized to offer individualized protective ventilation protocols, aiming to reduce ventilator-induced lung damage and support recovery outcomes.
Ebenbuild offers Clinical Decision Support and In Silico Trials.
Ebenbuild has 4 investors. Key investors include European Commission, Bayern Kapital, High-Tech Gründerfonds, and TechFounders.
Ebenbuild operates through Ebenbuild Gmbh.